Related Experiment Video
Updated: Feb 8, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Nutrient requirements for adults with ulcerative colitis over the disease course: a systematic scoping review
Samantha Plush1,2,3, Robert V Bryant1,2,3, Rachel H Davis1,2,3
1Department of Gastroenterology and Hepatology, The Queen Elizabeth Hospital, Woodville South, Australia.
Abstract:
Ulcerative colitis (UC) is a chronic inflammatory disease affecting the colonic mucosa. Nutrient requirements for UC are often extrapolated from studies in Crohn's disease (CD) yet physiological differences between UC and CD phenotypes may result in distinct nutrient requirements. This scoping review aimed to evaluate nutrient requirements for adults with UC. A scoping review with a systematic search strategy was conducted to June 2025. Data were extracted to identify nutrient requirements stratified by disease activity. Twenty-one studies involving 617 adults (274 male) were included. Measured resting energy expenditure (mREE) via indirect calorimetry ranged from 28.9 ± 3.2 to 31.5 ± 4.8 kcal/kg (fat free mass)/day (d) in quiescent UC, 26.4 kcal/kg/d in mild-moderate disease and 23.9 kcal/kg/d in acute severe UC (ASUC). Protein requirement, from historic studies, were 1.2-1.4 g/kg/d in ASUC. Protein requirements in quiescent or mild to moderate UC and whether elevated protein requirements persist in today's biologic era, remain unknown. Micronutrient requirement was investigated in mixed disease activity states confounding results. Evidence is insufficient to determine whether chronic inflammation in UC alters macro- and micronutrient requirements. Historical studies suggest increased protein requirements in ASUC, without evidence for quiescent or mild-moderate disease. Well-designed and disease activity-stratified studies are needed to establish evidence-based nutrient recommendations in UC.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The Scope of Physics

